350 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 7 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ICMTIsoprenylcysteine carboxyl methyltransferaseEnzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
INSIG1Insulin induced gene 1Plasma proteins
Predicted membrane proteins
Expressed in all
INSIG2Insulin induced gene 2Predicted membrane proteins
Expressed in all
ITPR2Inositol 1,4,5-trisphosphate receptor, type 2Plasma proteins
Predicted membrane proteins
Mixed
JKAMPJNK1/MAPK8-associated membrane proteinCancer-related genes
Predicted membrane proteins
Expressed in all
KCNA1Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel, Shab-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND1Potassium voltage-gated channel, Shal-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH1Potassium voltage-gated channel, subfamily H (eag-related), member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH4Potassium voltage-gated channel, subfamily H (eag-related), member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH5Potassium voltage-gated channel, subfamily H (eag-related), member 5Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH6Potassium voltage-gated channel, subfamily H (eag-related), member 6Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH7Potassium voltage-gated channel, subfamily H (eag-related), member 7Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNH8Potassium voltage-gated channel, subfamily H (eag-related), member 8Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNK1Potassium channel, subfamily K, member 1Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNK10Potassium channel, subfamily K, member 10Predicted membrane proteins
Tissue enhanced
KCNK12Potassium channel, subfamily K, member 12Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK13Potassium channel, subfamily K, member 13Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNK16Potassium channel, subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNK17Potassium channel, subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK18Potassium channel, subfamily K, member 18Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNK2Potassium channel, subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK5Potassium channel, subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNMA1Potassium large conductance calcium-activated channel, subfamily M, alpha member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ4Potassium voltage-gated channel, KQT-like subfamily, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNS2Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNT1Potassium channel, subfamily T, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNT2Potassium channel, subfamily T, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNU1Potassium channel, subfamily U, member 1Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
KIAA0195KIAA0195Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
LMBRD1LMBR1 domain containing 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
LPCAT3Lysophosphatidylcholine acyltransferase 3Enzymes
Predicted membrane proteins
Expressed in all
LPPR1Lipid phosphate phosphatase-related protein type 1 Predicted membrane proteins
Group enriched
LPPR3Hsa-mir-3187Enzymes
Predicted membrane proteins
Tissue enhanced
LPPR4Lipid phosphate phosphatase-related protein type 4 Enzymes
Predicted membrane proteins
Tissue enriched
LPPR5Lipid phosphate phosphatase-related protein type 5 Predicted membrane proteins
Group enriched

« prev | Page of 7 | next »